Skip to content
Screener
Lifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc.

LFCR

Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development and aseptic filling of complex, highly viscous sterile injectable pharmaceuticals and medical devices.

Market cap
$156.71M-45.6%
Revenue$124.9M-4.1%
Net income-$32.3M-47.1%
Free cash flow$230.0K+101%
EPS (diluted)-$0.97-24.4%
Trailing twelve months · change vs. prior year

Earnings

Next report

Date not yet announced

Financials

Q1 2027

Income statement

See full
Revenue$34.2M
Gross profit$12.1M
Operating income$2.6M
Net income-$6.2M
EPS (diluted)-$0.19

Balance sheet

See full
Cash & equivalents$17.2M
Total debt$8.1M
Total equity-$34.1M-3,860%
Total assets$229.5M

Cash flow

See full
Operating cash flow$2.5M
CapEx$1.6M
Free cash flow$880.0K

Valuation & ratios

Valuation

See full
Market cap$156.71M-45.6%
Enterprise value$147.53M
P/S1.3×

Returns & leverage

See full
Current ratio3.9×

Segments

By product

See full
HA manufacturing$18.6M
CDMO$15.6M

By segment

See full
Reportable Segment$34.2M

Competitors

Profile

Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development and aseptic filling of complex, highly viscous sterile injectable pharmaceuticals and medical devices. The company is a leading manufacturer of non-animal-sourced hyaluronic acid (HA) and provides end-to-end services from analytical development to commercial-scale manufacturing. Their value proposition centers on proprietary fermentation processes and specialized capabilities in handling difficult-to-fill formulations for global biopharmaceutical partners.

Competitive position

A leading U.S. manufacturer of non-animal-sourced HA with specialized expertise in high-viscosity aseptic filling that serves as a high-barrier-to-entry niche.

GeographiesUnited States, Europe, Japan, Brazil
Customer segmentsBiopharmaceutical Companies, Medical Device Companies, Research Institutions
Business modelB2B, Contract Manufacturing (CDMO), Proprietary Manufacturing Process
SuppliersRaw material suppliers for fermentation, Specialized laboratory equipment providers, Aseptic filling machinery manufacturers
CustomersBiopharmaceutical marketing and distribution firms, Orthopedic clinics, Ophthalmic surgeons, Wound care providers
Listed1996
Employees459.0
CEOPaul Josephs
FilingsSEC EDGAR

FAQ

What is Lifecore Biomedical, Inc.'s market cap?
Lifecore Biomedical, Inc. (LFCR) has a market capitalization of $156.7M and trades on NASDAQ.
What is Lifecore Biomedical, Inc.'s revenue and profitability?
Lifecore Biomedical, Inc. generated $124.9M in trailing twelve-month revenue with a net loss of $32.3M, representing a net margin of -30.0%. Gross margin stands at 31.3%, with free cash flow of $230.0K. The latest reported period is Q1 2027.
Who are Lifecore Biomedical, Inc.'s competitors?
Lifecore Biomedical, Inc.'s key competitors include Thermo Fisher Scientific, Baxter International, ADMA Biologics, Inc., and others. These companies compete in similar markets and product categories.
Who does Lifecore Biomedical, Inc. partner with?
Lifecore Biomedical, Inc.'s notable partners include BMO Harris Bank N.A., 22NW, LP.
Where is Lifecore Biomedical, Inc. headquartered?
Lifecore Biomedical, Inc. is headquartered in United States of America and employs approximately 459 people. It has been publicly traded since 1996.